雜志介紹

Ebiomedicine雜志介紹

《Ebiomedicine》是一本以English為主的開放獲取國際優秀期刊，中文名稱電子生物醫學，本刊主要出版、報道醫學-MEDICINE, RESEARCH & EXPERIMENTAL領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為9.7，最新CiteScore 指數為17.7。

本刊近期中國學者發表的論文主要有：

• Global prevalence of SARS-CoV-2 3CL protease mutations associated with nirmatrelvir or ensitrelvir resistance

  Author: Ip, Jonathan Daniel; Chu, Allen Wing-Ho; Chan, Wan-Mui; Leung, Rhoda Cheuk-Ying; Abdullah, Syed Muhammad Umer; Sun, Yanni; To, Kelvin Kai -Wang

• Comprehensive characterization of HER2-low breast cancers: implications in prognosis and treatment

  Author: Li, Yuyang; Tsang, Julia Y.; Tam, Fiona; Loong, Thomson; Tse, Gary M.

• Sustained activation of EGFR-ERK1/2 signaling limits the response to tigecycline-induced mitochondrial respiratory deficiency in liver cancer

  Author: Zhou, Yangyang; Wang, Siying; Wu, Wei; Ling, Jing; Li, Haoyu; Jia, Qi; Zheng, Jiaojiao; Zheng, Xingling; Yu, Ruobing; Wu, Qiangxin; Shi, Yaoping; Lieftink, Cor; Beijersbergen, Roderick L.; Yuan, Shengxian; Bernards, Rene; Jin, Haojie; Qin, Wenxin

• Dissecting the multifaceted impact of statin use on fatty liver disease: a multidimensional study

  Author: Ayada, Ibrahim; van Kleef, Laurens A.; Zhang, Huai; Liu, Kuan; Li, Pengfei; Abozaid, Yasir J.; Lavrijsen, Marla; Janssen, Harry L. A.; van der Laan, Luc J. W.; Ghanbari, Mohsen; Peppelenbosch, Maikel P.; Zheng, Ming-Hua; de Knegt, Robert J.; Pan, Qiuwei

英文介紹

Ebiomedicine雜志英文介紹

The effective translation of insights gained from biomedical research into improved human health is a global priority. To this end, Elsevier has looked to the leadership of its two leading brands, Cell and The Lancet, to guide the launch of a new comprehensive, online-only open access Elsevier journal, EBioMedicine, focused on forming a community that spans this interface and creates a valuable opportunity for dialogue and collaboration between their respective audiences.